NFE2L2 Gene Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung Cancer (NCT05275673) | Faeth Therapeutics | 2022-07-21 |
| NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial (NCT04698681) | Calithera Biosciences, Inc | 2021-01-19 |
Track NFE2L2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.